Weight increased in Sprintec - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Weight increased, when it was recovered, drug effectiveness, race, and more among people who take Sprintec (ethinyl estradiol; norgestimate). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Weight increased?

Weight increased is found to be associated with 2,905 drugs and 3,899 conditions by eHealthMe. Check the latest studies of Weight increased.

On Dec, 24, 2025

23 people who have Weight increased while taking Sprintec were studied.

Severity of Weight increased *:

least: 0.0 %
moderate: 66.67 %
severe: 27.78 %
most severe: 5.56 %

When people recovered from Weight increased *:

while on drug: 6.25 %
after off the drug: 0.0 %
not yet: 93.75 %

Effectiveness of Sprintec *:

not at all: 0.0 %
somewhat: 0.0 %
moderate: 11.11 %
high: 44.44 %
very high: 44.44 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 5.26 %
Hispanic: 5.26 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 5.26 %
White, Non-Hispanic: 84.21 %

Time on Sprintec *:

Gender of people when taking Sprintec *:

female: 95.65 %
male: 4.35 %

Age of people when taking Sprintec *:

Conditions people have *:

Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 5 people, 21.74%
Depression: 4 people, 17.39%
High Blood Pressure: 4 people, 17.39%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 3 people, 13.04%
Insomnia (sleeplessness): 3 people, 13.04%
Stress And Anxiety: 3 people, 13.04%
Bipolar Disorder (mood disorder): 3 people, 13.04%
Allergies: 2 people, 8.70%
Asthma: 2 people, 8.70%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%

Other drugs people take besides Sprintec *:

Zoloft: 3 people, 13.04%
Melatonin: 3 people, 13.04%
Lisinopril: 2 people, 8.70%
Spironolactone: 2 people, 8.70%
Seroquel: 2 people, 8.70%
Concerta: 2 people, 8.70%
Clonazepam: 2 people, 8.70%
Cetirizine Hydrochloride: 2 people, 8.70%
Phentermine: 2 people, 8.70%
Multivitamin: 2 people, 8.70%

Other side effects people have besides Weight increased *:

Fatigue (feeling of tiredness): 5 people, 21.74%
Insomnia (sleeplessness): 3 people, 13.04%
Weight Loss: 2 people, 8.70%
Memory Loss: 2 people, 8.70%
Drowsiness: 2 people, 8.70%
Itching: 2 people, 8.70%
Joint Pain: 2 people, 8.70%
Headache (pain in head): 2 people, 8.70%
Abdominal Pain: 2 people, 8.70%
Chapped Lips (cracking, fissuring, and peeling of the skin f lip): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Sprintec and have Weight increased?

Check whether Weight increased is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Weight increased in Sprintec

How the study uses the data?

The study is based on ethinyl estradiol; norgestimate (the active ingredients of Sprintec). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.